Emicizumab, designated bROmI is representing a important step forward in treating this inherited disease . This novel therapy functions as a prothrombin activator , mimicking factor VIII, a component often https://harleyndwx854285.activoblog.com/51418261/introducing-hope-for-hemophilia-care